106 related articles for article (PubMed ID: 22766564)
1. The molecular mechanism of the anticancer effect of atorvastatin: DNA microarray and bioinformatic analyses.
Gao Y; Lu XC; Yang HY; Liu XF; Cao J; Fan L
Int J Mol Med; 2012 Oct; 30(4):765-74. PubMed ID: 22766564
[TBL] [Abstract][Full Text] [Related]
2. Comparative expression profiling in primary and immortalized endothelial cells: changes in gene expression in response to hydroxy methylglutaryl-coenzyme A reductase inhibition.
Boerma M; Burton GR; Wang J; Fink LM; McGehee RE; Hauer-Jensen M
Blood Coagul Fibrinolysis; 2006 Apr; 17(3):173-80. PubMed ID: 16575254
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of atorvastatin against oxidized LDL-induced downregulation of KLF expression in EA.hy926 cells.
Gao Y; Liu XF; Lu XC; Ma C; Cao J; Fan L
Int J Mol Med; 2012 Aug; 30(2):330-6. PubMed ID: 22614632
[TBL] [Abstract][Full Text] [Related]
4. HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes.
Assmus B; Urbich C; Aicher A; Hofmann WK; Haendeler J; Rössig L; Spyridopoulos I; Zeiher AM; Dimmeler S
Circ Res; 2003 May; 92(9):1049-55. PubMed ID: 12676819
[TBL] [Abstract][Full Text] [Related]
5. The effect of atorvastatin on mRNA levels of inflammatory genes expression in human peripheral blood lymphocytes by DNA microarray.
Wang Y; Chang H; Zou J; Jin X; Qi Z
Biomed Pharmacother; 2011 Mar; 65(2):118-22. PubMed ID: 21216561
[TBL] [Abstract][Full Text] [Related]
6. Systemic evaluation of gene expression changes in major target organs induced by atorvastatin.
Kato N; Liang YQ; Ochiai Y; Jesmin S
Eur J Pharmacol; 2008 Apr; 584(2-3):376-89. PubMed ID: 18295756
[TBL] [Abstract][Full Text] [Related]
7. Stimulatory effects of atorvastatin on extracellular nucleotide degradation in human endothelial cells.
Osman L; Amrani M; Isley C; Yacoub MH; Smolenski RT
Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1125-8. PubMed ID: 17065076
[TBL] [Abstract][Full Text] [Related]
8. Different statins produce highly divergent changes in gene expression profiles of human hepatoma cells: a pilot study.
Leszczynska A; Gora M; Plochocka D; Hoser G; Szkopinska A; Koblowska M; Iwanicka-Nowicka R; Kotlinski M; Rawa K; Kiliszek M; Burzynska B
Acta Biochim Pol; 2011; 58(4):635-9. PubMed ID: 22132374
[TBL] [Abstract][Full Text] [Related]
9. Simvastatin and atorvastatin enhance gene expression of collagen type 1 and osteocalcin in primary human osteoblasts and MG-63 cultures.
Ruiz-Gaspa S; Nogues X; Enjuanes A; Monllau JC; Blanch J; Carreras R; Mellibovsky L; Grinberg D; Balcells S; Díez-Perez A; Pedro-Botet J
J Cell Biochem; 2007 Aug; 101(6):1430-8. PubMed ID: 17252541
[TBL] [Abstract][Full Text] [Related]
10. Angiogenic transcriptome of human microvascular endothelial cells: Effect of hypoxia, modulation by atorvastatin.
Loboda A; Jazwa A; Jozkowicz A; Molema G; Dulak J
Vascul Pharmacol; 2006 Apr; 44(4):206-14. PubMed ID: 16481221
[TBL] [Abstract][Full Text] [Related]
11. Decreased ABCB1 mRNA expression induced by atorvastatin results from enhanced mRNA degradation in HepG2 cells.
Rodrigues AC; Curi R; Hirata MH; Hirata RD
Eur J Pharm Sci; 2009 Jun; 37(3-4):486-91. PubMed ID: 19394420
[TBL] [Abstract][Full Text] [Related]
12. Atorvastatin partially prevents an inflammatory barrier breakdown of cultured human brain endothelial cells at a pharmacologically relevant concentration.
Buttmann M; Lorenz A; Weishaupt A; Rieckmann P
J Neurochem; 2007 Aug; 102(4):1001-8. PubMed ID: 17442054
[TBL] [Abstract][Full Text] [Related]
13. Effect of atorvastatin on in vitro expression of resistin in adipocytes and monocytes/macrophages and effect of atorvastatin treatment on serum resistin levels in patients with type 2 diabetes.
Ichida Y; Hasegawa G; Fukui M; Obayashi H; Ohta M; Fujinami A; Ohta K; Nakano K; Yoshikawa T; Nakamura N
Pharmacology; 2006; 76(1):34-9. PubMed ID: 16227702
[TBL] [Abstract][Full Text] [Related]
14. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor Atorvastatin mediated effects depend on the activation status of target cells in PLP-EAE.
Mix E; Ibrahim SM; Pahnke J; Glass A; Mazón-Peláez I; Lemcke S; Koczan D; Gimsa U; Bansemer S; Scheel T; Karopka T; Böttcher T; Müller J; Dazert E; Antipova V; Hoffrogge R; Wree A; Zschiesche M; Strauss U; Kundt G; Warzok R; Gierl L; Rolfs A
J Autoimmun; 2006 Dec; 27(4):251-65. PubMed ID: 17085013
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-34a regulates the longevity-associated protein SIRT1 in coronary artery disease: effect of statins on SIRT1 and microRNA-34a expression.
Tabuchi T; Satoh M; Itoh T; Nakamura M
Clin Sci (Lond); 2012 Aug; 123(3):161-71. PubMed ID: 22364258
[TBL] [Abstract][Full Text] [Related]
16. The effects of high glucose and atorvastatin on endothelial cell matrix production.
McGinn S; Poronnik P; Gallery ED; Pollock CA
Diabet Med; 2004 Oct; 21(10):1102-7. PubMed ID: 15384957
[TBL] [Abstract][Full Text] [Related]
17. The human primary hepatocyte transcriptome reveals novel insights into atorvastatin and rosuvastatin action.
Hafner M; Juvan P; Rezen T; Monostory K; Pascussi JM; Rozman D
Pharmacogenet Genomics; 2011 Nov; 21(11):741-50. PubMed ID: 21869732
[TBL] [Abstract][Full Text] [Related]
18. Antitumor and apoptosis promoting properties of atorvastatin, an inhibitor of HMG-CoA reductase, against Dalton's Lymphoma Ascites tumor in mice.
Ajith TA; Anu V; Riji T
J Exp Ther Oncol; 2008; 7(4):291-8. PubMed ID: 19227009
[TBL] [Abstract][Full Text] [Related]
19. Atorvastatin suppresses aldosterone-induced neonatal rat cardiac fibroblast proliferation by inhibiting ERK1/2 in the genomic pathway.
Wang Q; Cui W; Zhang HL; Hu HJ; Zhang YN; Liu DM; Liu J
J Cardiovasc Pharmacol; 2013 Jun; 61(6):520-7. PubMed ID: 23429584
[TBL] [Abstract][Full Text] [Related]
20. Multiple statistical methods for assessing differential gene expression in microarray data of diabetic model rats to predict the molecular mechanism of atorvastatin on anti-atherogenesis.
Xu L; Feng B; Wang H; Li X
Exp Clin Endocrinol Diabetes; 2013 May; 121(5):272-9. PubMed ID: 23450332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
